A series of Val-Leu based peptidic aldehydes containing either a furan or thiophene at the Nterminus was prepared and assayed against ovine m-calpain. In general, potency is favoured by a 2- substituted (rather than 3-substituted) heterocycle, a thiophene rather than a furan, and a shorter chain length at the N-terminus. Molecular docking experiments provide some rationale for these observations.Jones, Seth A.; Jones, Matthew A.; McNabb, Stephen B.; Aitken, Steven G.; Coxon, James M. And Abell, Andrew
We have designed a highly specific inhibitor of calpain by mimicking a natural protein–protein inter...
Calpain inhibitors are possible therapeutic agents in the treatment of cataracts. These covalent inh...
The work in this thesis reports studies directed to developing a calpain cysteine protease inhibito...
A series of N-heterocyclic dipeptide aldehydes 4–13 have been synthesised and evaluated as inhibitor...
The physiological roles of calpains are discussed, as are the associated pathological disorders that...
The 26S proteasome and calpain are linked to a number of important human diseases. Here, we report a...
Ring closing metathesis and cross metathesis approaches to a new macrocyclic peptidomimetic aldehyde...
This thesis reports the development of potent and selective inhibitors of m-calpain for the treatmen...
Two new series of 15-membered macrocyclic peptidomimetics, in which the P1 and P3 residues of the pe...
Two new series of 15-membered macrocyclic peptidomimetics, in which the P1 and P3 residues of the pe...
Our previously reported structures of calpain bound to its endogenous inhibitor calpastatin have mot...
In the course of the development of calpain inhibitors, we report the synthesis of eight-membered cy...
Dimeric calpains constitute a promising therapeutic target for many diseases such as cardiovascular,...
This investigation involved the synthesis of potential CA clan cysteine inhibitors of m-calpain and...
The photoswitchable N-terminal diazo and triazene-dipeptide aldehydes 8a-d, 10a,b, and 17a,b present...
We have designed a highly specific inhibitor of calpain by mimicking a natural protein–protein inter...
Calpain inhibitors are possible therapeutic agents in the treatment of cataracts. These covalent inh...
The work in this thesis reports studies directed to developing a calpain cysteine protease inhibito...
A series of N-heterocyclic dipeptide aldehydes 4–13 have been synthesised and evaluated as inhibitor...
The physiological roles of calpains are discussed, as are the associated pathological disorders that...
The 26S proteasome and calpain are linked to a number of important human diseases. Here, we report a...
Ring closing metathesis and cross metathesis approaches to a new macrocyclic peptidomimetic aldehyde...
This thesis reports the development of potent and selective inhibitors of m-calpain for the treatmen...
Two new series of 15-membered macrocyclic peptidomimetics, in which the P1 and P3 residues of the pe...
Two new series of 15-membered macrocyclic peptidomimetics, in which the P1 and P3 residues of the pe...
Our previously reported structures of calpain bound to its endogenous inhibitor calpastatin have mot...
In the course of the development of calpain inhibitors, we report the synthesis of eight-membered cy...
Dimeric calpains constitute a promising therapeutic target for many diseases such as cardiovascular,...
This investigation involved the synthesis of potential CA clan cysteine inhibitors of m-calpain and...
The photoswitchable N-terminal diazo and triazene-dipeptide aldehydes 8a-d, 10a,b, and 17a,b present...
We have designed a highly specific inhibitor of calpain by mimicking a natural protein–protein inter...
Calpain inhibitors are possible therapeutic agents in the treatment of cataracts. These covalent inh...
The work in this thesis reports studies directed to developing a calpain cysteine protease inhibito...